Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-24-007361
Filing Date
2024-11-18
Accepted
2024-11-18 16:39:38
Documents
34
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q agtx_10q.htm   iXBRL 10-Q 442794
2 CERTIFICATION agtx_ex311.htm EX-31.1 13756
3 CERTIFICATION agtx_ex312.htm EX-31.2 10702
4 CERTIFICATION agtx_ex321.htm EX-32.1 4049
  Complete submission text file 0001477932-24-007361.txt   1773929

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA agtx-20240930.xsd EX-101.SCH 17741
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE agtx-20240930_lab.xml EX-101.LAB 114811
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE agtx-20240930_cal.xml EX-101.CAL 26198
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE agtx-20240930_pre.xml EX-101.PRE 88929
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE agtx-20240930_def.xml EX-101.DEF 34588
37 EXTRACTED XBRL INSTANCE DOCUMENT agtx_10q_htm.xml XML 137332
Mailing Address 32932 PACIFIC COAST HIGHWAY #14-254 DANA POINT CA 92629
Business Address 32932 PACIFIC COAST HIGHWAY #14-254 DANA POINT CA 92629 321-229-2014
Agentix Corp. (Filer) CIK: 0001603345 (see all company filings)

EIN.: 462876282 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-55383 | Film No.: 241472014
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)